These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


87 related items for PubMed ID: 16020916

  • 1. Platelet aggregation and vasoconstriction related to platelet cyclooxygenase and 12-lipoxygenase pathways.
    Michibayashi T.
    J Atheroscler Thromb; 2005; 12(3):154-62. PubMed ID: 16020916
    [Abstract] [Full Text] [Related]

  • 2. Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits.
    Michibayashi T.
    Int Angiol; 2002 Sep; 21(3):260-7. PubMed ID: 12384648
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Different types of vasocontractile responses to noradrenaline in the presence of platelets with platelet activating factor.
    Michibayashi T.
    J Smooth Muscle Res; 1997 Jun; 33(3):117-26. PubMed ID: 9533823
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways.
    Lauri D, Cerletti C, de Gaetano G.
    J Lab Clin Med; 1985 Jun; 105(6):653-8. PubMed ID: 3923145
    [Abstract] [Full Text] [Related]

  • 11. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S, Krauze-Brzósko K, Manarini S, Evangelista V, Cerletti C.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):79-83. PubMed ID: 15044038
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of PAF-induced platelet aggregation in man.
    Küster LJ, Filep J, Frölich JC.
    Thromb Res; 1986 Aug 15; 43(4):425-33. PubMed ID: 3764802
    [Abstract] [Full Text] [Related]

  • 13. Effect of the PAF-receptor antagonist SM-12502 on human platelets.
    Köller M, Hilger RA, König W.
    Inflammation; 1996 Feb 15; 20(1):71-85. PubMed ID: 8926050
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit.
    Honey AC, Lad N, Tuffin DP.
    Thromb Haemost; 1986 Aug 20; 56(1):80-5. PubMed ID: 3775692
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.
    Ciabattoni G, Montuschi P, Currò D, Togna G, Preziosi P.
    Br J Pharmacol; 1993 May 20; 109(1):243-50. PubMed ID: 8495242
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Platelet-activating factor-induced vasoconstriction in rat isolated, perfused hearts: contribution of cyclo-oxygenase and lipoxygenase arachidonic acid metabolites.
    Stewart AG, Piper PJ.
    Pharmacol Res Commun; 1986 Aug 20; 18 Suppl():163-72. PubMed ID: 3095850
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.